Monday, 10 November 2014 08:05

Talent Demand in Healthcare IT Continues: Quest Diagnostics, M*Modal & Others Keep Hiring Featured

Written by
Rate this item
(0 votes)

Quest Diagnostics Appoints Director with Scientific and Commercial Experience in Pharma and Biotech Industries

Quest Diagnostics, provider of diagnostic testing, information and services, elected Jeffrey M. Leiden, M.D., Ph.D., 58, to serve as a director. Dr. Leiden is the Chairman, President and CEO of Vertex Pharmaceuticals. Prior to that, Dr. Leiden was a Managing Director at Clarus Ventures, President and COOand Chief Scientific Officer at Abbott Laboratories, Chief of Cardiology at the University of Chicago, the Elkan R. Blout Professor of Biological Sciences at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School. 

M*Modal’s Taps New CEO from Experian Health

M*Modal, a leading provider of clinical documentation and Speech Understanding™ solutions, named healthcare IT industry veteran Scott MacKenzie as CEO and a member of the board. MacKenzie joins M*Modal having served as CEO of Passport Health Communications, which was purchased by Experian in 2013. Since the acquisition, he has been President of Experian Health. Prior to that, MacKenzie was part of McKesson as President of RelayHealth Pharmacy Solutions and also held executive positions at Cerner.

Former U.S. Senator and Former Medco CEO Joins Board of Telehealth Services Provider Teladoc

William Frist, a former U.S. senator, and David Snow, former chair and CEO of Medco Health Solutions, have been named to the board of Teladoc, a telehealth services provider.

Senator Frist is a world-renowned cardiothoracic transplant surgeon and a leading authority on health care policy. During his tenure on Capitol Hill, he served on both the Health and Finance Committees, where he was instrumental in passing health care reform legislation and ultimately served as Senate Majority Leader. Senator Frist brings to Teladoc decades of experience in providing top quality patient care, driving health care policy and reform, and a reputation for championing innovations that deliver improved health care outcomes.

David B. Snow, Jr., is a health care industry veteran, innovator and entrepreneur who has created and implemented solutions to manage the rising costs of health care. Most recently, he served as the chairman and CEO of Medco Health Solutions, one of the nation’s largest pharmacy benefit managers. Prior to joining Medco, he served as president and COO at Empire BlueCross BlueShield. Currently, Snow serves as the chairman and CEO of Cedar Gate Technologies, a health care IT data analytics company.

Laboratory and Health Technology Company Medytox Solutions Names New CEO

Seamus Lagan, former CEO of three Medytox Solution subsidiaries, has been named CEO of Medytox, a lab and health IT company operator. He is a longtime consultant to private companies in the United States and abroad.

SeeChange Health Appoints Towers Watson Exec as CEO

SeeChange Health appointed Bryce Williams as President and CEO. Williams succeeds Martin Watson, SeeChange’s founder who has been in the role since 2008, as SeeChange focuses exclusively on its consumer engagement and health improvement platform. Williams is former managing director of the exchange solutions business at benefits consultant Towers Watson. Williams co-founded Extend Health and was its President and CEO from 2004 through the company’s acquisition by Towers Watson in 2012.

Hearst Drug Database Subsidiary First Databank Promotes EVP as President

Charles Tuchinda, former EVP of First Databank (FDB), a drug database subsidiary of the Hearst Corporation, has been named president of First Databank. Prior to his role at FDB, Tuchinda was Hearst Business Media’s Chief Innovation Officer for Healthcare. His work led to the commercialization of new products, including FDB AlertSpace. Prior to joining Hearst, Tuchinda served as VP of BD and product strategy; VP of Acute Care Solutions; VP of content solutions at Eclipsys (now Allscripts).

Tuchinda succeeds Gregory Dorn, MD, who is president of Hearst Health.

Date Range: October 15th - November 4th

Read 2510 times Last modified on Tuesday, 03 April 2018 08:13
Dora Vell

Dora Vell is the Managing Partner of Vell Executive Search, a boutique executive search firm in Boston focused on recruiting technology executives and board members. Vell has successfully completed numerous board member and C-level executive searches, including CEOs, COOs, CIOs, and Vice Presidents - at both public and private companies.

Prior to founding the firm in 2005, Vell was a Partner at Heidrick & Struggles' Technology practice for seven years.  Before her career in executive search, she worked at IBM for 11 years, managing software engineering organizations of 100 people and software sales organizations with revenues of $150 million. She has also served as an executive assistant to the CEO of IBM Canada for one year.

Vell holds seven worldwide software patents. She has published several Business of Leadership reports on governance and leadership and has been quoted in numerous articles including The Wall Street Journal, Forbes, Business Week, Fortune, Agenda Week, MSNBC, Mass High Tech, the OPUS for the World Economic Forum, Boston Business Journal, The Globe & Mail, CIO Magazine, and IEEE. She also has been a featured speaker on leadership at numerous conferences and at Columbia University's MBA program.

Vell is a member of the National Association of Corporate Directors (NACD), the Boston CEO Roundtable. She has served on the boards of Framingham State, Entrepreneur's Organization, Goodwill, Mary Centre for developmentally handicapped adults, garage.ca, and RBC Capital Partners.

She has received an MBA from the University of Toronto, a Master in Computer Science from the University of Waterloo, and a Bachelor in Computer Science from Carleton. She has also completed the MIT Entrepreneurial Master’s program.

www.vell.com/

Leave a comment